CervoMed (NasdaqCM:CRVO) FY Conference March 23, 2026 03:00 PM ET Company ParticipantsMatt Winton - CCO and CBOModeratorGood afternoon, everyone. I am Boobalan Pachaiyappan, Managing Director and Senior Biotech Analyst at Roth Capital Partners. With me today is Matt Winton, who is the Chief Commercial Officer and Chief Business Officer of CervoMed. For those who are new to the story, CervoMed is developing oral drugs for neurodegenerative diseases, including dementia with Lewy bodies, ALS, and FTD, and so o ...

Prenetics Global (NasdaqGM:PRE) FY Conference March 23, 2026 03:00 PM ET Company ParticipantsDanny Yeung - CEO and Co-founderJason Wersland - FounderNate Raabe - Managing PartnerShadi Bakour - Co-founder and CEOShahab Elmi - Founder and CEOConference Call ParticipantsNone - AnalystNone - AnalystNate RaabeAll right, we're missing a panelist here. I think he's talking with Mr. Johnson out there, so he may join us later. We're gonna go ahead and get started here. There'll be people trickling in. My name is Nat ...

Astera Labs (NasdaqGS:ALAB) FY Conference March 23, 2026 02:30 PM ET Company ParticipantsNick Aberle - VP of Finance, Investor Relations, and TreasurerConference Call ParticipantsSuji Desilva - Managing Director and Senior Research AnalystNone - AnalystNone - AnalystSuji DesilvaI'm a systems analyst at Roth. Usually, you know, I have to go back and look at somebody's bio when I'm meeting them, but I've known Nick most of his career. We started talking to each other when he was working at Netlogic and Broadc ...

Cronos Group (NasdaqGM:CRON) FY Conference March 23, 2026 02:30 PM ET Company ParticipantsMike Gorenstein - Chairman, President, and CEOConference Call ParticipantsNone - AnalystNoneIn a minute. Yeah, I think the clock is still. There it is. All right. I'm ready if you're ready. All right. Good morning, everybody. This is the consumer track. We're in the blue room, where we're about to hear from Cronos Group Chairman and CEO Mike Gorenstein. Mike, thank you for being here. Cronos is a leading cannabis LP, w ...

Amdocs (NasdaqGS:DOX) Update / briefing March 23, 2026 02:00 PM ET Company ParticipantsAnthony Goonetilleke - Group President, Technology and Head of StrategyLiliana Schwartz-Brunner - General Manager and Head of Global Strategic PartnersMatthew Smith - Head of Investor RelationsPilar Abalo - Global Head of ConsultingShlomo Rosenbaum - Managing DirectorTomer Zilberman - VP of Equity ResearchNone - Video NarratorConference Call ParticipantsTimothy Horan - Managing Director and Senior AnalystMatthew SmithEver ...

CapsoVision (NasdaqCM:CV) FY Conference March 23, 2026 01:30 PM ET Company ParticipantsDavid Garcia - Senior VP of FinanceDoug Atkinson - Senior VP of Global SalesJohnny Wang - Co-Founder, President, and CEOConference Call ParticipantsKyle Bauser - Senior Research AnalystKyle BauserMy name is Kyle Bauser, and I'm a Senior Research Analyst with Roth covering the medical device sector. Today we have CapsoVision here for a fireside chat. We are joined by Johnny Wang, Co-founder, President, and CEO, David Garci ...

Bausch + Lomb (NYSE:BLCO) Update / briefing March 23, 2026 01:30 PM ET Company ParticipantsBrent Saunders - Chairman and CEOCathleen McCabe - Strategic Medical AdvisorKelly Swaim - SVP of Surgical R&DMayssa Attar - SVP of Pharmaceuticals and Consumer R&DYehia Hashad - EVP of R&D and Chief Medical OfficerConference Call ParticipantsLarry Biegelsen - Medical Device AnalystLarry BiegelsenGood afternoon. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. Welcome to the next call in our 2026 MedTech ...

Arcturus Therapeutics (NasdaqGM:ARCT) FY Conference March 23, 2026 12:30 PM ET Company ParticipantsJoe Payne - CEOConference Call ParticipantsAdam Walsh - Senior Research AnalystAdam WalshGood morning, and thank you for joining us again for the 38th Annual ROTH Conference. My name is Adam Walsh. I'm a Senior Research Analyst with ROTH, covering the biotechnology sector. Our next presenter is Joe Payne, CEO of Arcturus Therapeutics. Joe, thanks for joining us.Joe PayneAdam, it's good to be with you. Thanks f ...

BL1107 FIRST GLAUCOMA THERAPY TO IMPROVE VISUAL FUNCTION THROUGH NEUROPROTECTION ELIOS FIRST CLINICIALLY VALIDATED IMPLANT-FREE MIGS EXCIMER LASER Disclaimers Forward-Looking Statements This presentation contains forward-looking information and statements, within the meaning of applicable securities laws (collectively, "forward-looking statements"), including, but not limited to, statements our focus on pipeline innovation, the success of our pipeline products and R&D programs, the existence of potential ga ...

Kura Sushi USA (NasdaqGM:KRUS) FY Conference March 23, 2026 12:00 PM ET Company ParticipantsBenjamin Porten - SVP of Investor Relations and System DevelopmentHajime Uba - President and CEOJeff Uttz - CFOConference Call ParticipantsGeorge Kelly - Managing Director, Senior Research AnalystNone - AnalystGeorge KellyOkay, let's get started. I'm George Kelly with Roth. Excited to have the team from Kura Sushi with me on stage today. Thanks for being here. From the team, we have Hajime Uba, who's CEO. Jeff Uttz i ...